Sino Biopharmaceutical Statistics
Total Valuation
SBMFF has a market cap or net worth of 15.62 billion. The enterprise value is 16.25 billion.
| Market Cap | 15.62B |
| Enterprise Value | 16.25B |
Important Dates
The next estimated earnings date is Friday, March 27, 2026.
| Earnings Date | Mar 27, 2026 |
| Ex-Dividend Date | Aug 29, 2025 |
Share Statistics
| Current Share Class | 17.88B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -2.10% |
| Shares Change (QoQ) | -0.85% |
| Owned by Insiders (%) | 50.79% |
| Owned by Institutions (%) | 16.56% |
| Float | 8.80B |
Valuation Ratios
The trailing PE ratio is 28.90 and the forward PE ratio is 23.06.
| PE Ratio | 28.90 |
| Forward PE | 23.06 |
| PS Ratio | 3.66 |
| PB Ratio | 2.44 |
| P/TBV Ratio | 3.70 |
| P/FCF Ratio | 19.05 |
| P/OCF Ratio | 16.71 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.68, with an EV/FCF ratio of 19.82.
| EV / Earnings | 30.08 |
| EV / Sales | 3.79 |
| EV / EBITDA | 16.68 |
| EV / EBIT | 20.31 |
| EV / FCF | 19.82 |
Financial Position
The company has a current ratio of 1.36, with a Debt / Equity ratio of 0.26.
| Current Ratio | 1.36 |
| Quick Ratio | 1.14 |
| Debt / Equity | 0.26 |
| Debt / EBITDA | 1.71 |
| Debt / FCF | 2.04 |
| Interest Coverage | 21.69 |
Financial Efficiency
Return on equity (ROE) is 15.40% and return on invested capital (ROIC) is 13.43%.
| Return on Equity (ROE) | 15.40% |
| Return on Assets (ROA) | 5.07% |
| Return on Invested Capital (ROIC) | 13.43% |
| Return on Capital Employed (ROCE) | 11.47% |
| Weighted Average Cost of Capital (WACC) | 8.04% |
| Revenue Per Employee | 185,063 |
| Profits Per Employee | 23,438 |
| Employee Count | 23,056 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 2.83 |
Taxes
In the past 12 months, SBMFF has paid 120.07 million in taxes.
| Income Tax | 120.07M |
| Effective Tax Rate | 11.27% |
Stock Price Statistics
The stock price has increased by +110.13% in the last 52 weeks. The beta is 0.81, so SBMFF's price volatility has been lower than the market average.
| Beta (5Y) | 0.81 |
| 52-Week Price Change | +110.13% |
| 50-Day Moving Average | 0.80 |
| 200-Day Moving Average | 0.56 |
| Relative Strength Index (RSI) | 37.23 |
| Average Volume (20 Days) | 1,157 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SBMFF had revenue of 4.27 billion and earned 540.39 million in profits. Earnings per share was 0.03.
| Revenue | 4.27B |
| Gross Profit | 3.49B |
| Operating Income | 801.24M |
| Pretax Income | 1.07B |
| Net Income | 540.39M |
| EBITDA | 960.41M |
| EBIT | 801.24M |
| Earnings Per Share (EPS) | 0.03 |
Balance Sheet
The company has 2.77 billion in cash and 1.67 billion in debt, with a net cash position of 1.10 billion.
| Cash & Cash Equivalents | 2.77B |
| Total Debt | 1.67B |
| Net Cash | 1.10B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 6.39B |
| Book Value Per Share | 0.26 |
| Working Capital | 1.25B |
Cash Flow
In the last 12 months, operating cash flow was 934.85 million and capital expenditures -114.95 million, giving a free cash flow of 819.90 million.
| Operating Cash Flow | 934.85M |
| Capital Expenditures | -114.95M |
| Free Cash Flow | 819.90M |
| FCF Per Share | n/a |
Margins
Gross margin is 81.77%, with operating and profit margins of 18.78% and 12.67%.
| Gross Margin | 81.77% |
| Operating Margin | 18.78% |
| Pretax Margin | 24.96% |
| Profit Margin | 12.67% |
| EBITDA Margin | 22.51% |
| EBIT Margin | 18.78% |
| FCF Margin | 19.22% |
Dividends & Yields
This stock pays an annual dividend of 0.01, which amounts to a dividend yield of 1.48%.
| Dividend Per Share | 0.01 |
| Dividend Yield | 1.48% |
| Dividend Growth (YoY) | 49.67% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 47.69% |
| Buyback Yield | 2.10% |
| Shareholder Yield | 3.58% |
| Earnings Yield | 3.46% |
| FCF Yield | 5.25% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SBMFF has an Altman Z-Score of 2.54 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.54 |
| Piotroski F-Score | 6 |